Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Remy Dulery, M.D., Ph.D.

Concepts (105)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation16202457170.920 Why?
Graft vs Host Disease8202430490.620 Why?
Leukemia1202315190.470 Why?
Hematologic Neoplasms3202319070.450 Why?
Transplantation Conditioning7202316010.430 Why?
Hodgkin Disease3202213840.310 Why?
Photopheresis22020350.310 Why?
Immunoglobulin Heavy Chains220166480.200 Why?
Transplantation, Homologous9202448330.200 Why?
Antigens, CD34120246570.200 Why?
Whole-Body Irradiation120234350.200 Why?
Papilledema120221300.180 Why?
Leukemia, Myeloid, Acute3202236260.180 Why?
Waldenstrom Macroglobulinemia3201610770.160 Why?
Takayasu Arteritis120201060.150 Why?
Antilymphocyte Serum120204920.150 Why?
Biliary Tract Diseases120191590.150 Why?
Treatment Failure1202426610.150 Why?
Salvage Therapy2202412730.150 Why?
Immunoglobulin Light Chains220162890.150 Why?
Cyclophosphamide2202122270.150 Why?
Lymphoma, B-Cell120249450.140 Why?
Lymphoma, Non-Hodgkin1202413750.130 Why?
Blood Viscosity120161250.130 Why?
Adenovirus Infections, Human12016760.120 Why?
Niacinamide120174180.120 Why?
Immunoglobulin lambda-Chains12014830.120 Why?
Drug Resistance, Multiple, Bacterial120195910.110 Why?
Immunoglobulin kappa-Chains120141710.110 Why?
Adenoviruses, Human120162570.110 Why?
Phenylurea Compounds120175310.110 Why?
Renal Insufficiency120198120.110 Why?
Myeloma Proteins12011710.090 Why?
Immunoglobulin M1201615280.090 Why?
Perioperative Care1201910430.090 Why?
Immunoglobulin A120149920.090 Why?
Multiple Myeloma2202251960.090 Why?
Liver Diseases1201913050.090 Why?
Retrospective Studies112024817620.080 Why?
Lymphoma, Large B-Cell, Diffuse1202014370.080 Why?
Bacteremia120169860.080 Why?
Young Adult72024600660.070 Why?
Autoimmune Diseases1202022570.070 Why?
Transplantation, Autologous2202421200.070 Why?
Neoplasm Recurrence, Local2202294190.060 Why?
Drug Resistance, Neoplasm1202153410.060 Why?
France220194970.060 Why?
Acute Disease3202272430.060 Why?
Humans2420247681660.050 Why?
Adult1020242236460.050 Why?
Middle Aged1020242234920.050 Why?
Aged820241715040.050 Why?
Immunosuppressive Agents3202042060.050 Why?
Immunotherapy, Adoptive2202215120.050 Why?
Iris120222320.050 Why?
Chronic Disease3202293840.040 Why?
Treatment Outcome72024653710.040 Why?
Antibodies, Monoclonal1201692630.040 Why?
Hepatitis, Viral, Human120191410.040 Why?
Pneumonia, Viral1201632380.040 Why?
Thrombotic Microangiopathies120191240.040 Why?
Antigens, CD19120204460.030 Why?
Iron Overload120192450.030 Why?
Nephelometry and Turbidimetry12016910.030 Why?
Survival Analysis22020101010.030 Why?
Antineoplastic Agents22017136760.030 Why?
Isocitrate Dehydrogenase120229510.030 Why?
Nephrotic Syndrome120193810.030 Why?
Adolescent52024891690.030 Why?
Male1120243647190.030 Why?
Transplantation Chimera120175940.030 Why?
Female1120243971920.030 Why?
Remission Induction1202024100.030 Why?
T-Lymphocytes22022102660.030 Why?
fms-Like Tyrosine Kinase 3120174940.030 Why?
Anti-Infective Agents120199830.020 Why?
Enzyme Inhibitors1202237280.020 Why?
Fatal Outcome1201618360.020 Why?
Receptors, Antigen, T-Cell1202025680.020 Why?
Incidence22019215380.020 Why?
Bone Marrow1202029350.020 Why?
Severity of Illness Index22019159480.020 Why?
DNA, Viral1201622040.020 Why?
Chemotherapy, Adjuvant1201735560.020 Why?
Disease Management1201925360.020 Why?
Time Factors22019402180.020 Why?
Prognosis22021300100.020 Why?
Survival Rate12021128400.020 Why?
Disease-Free Survival1201768470.020 Why?
Polymerase Chain Reaction1201660820.020 Why?
Feasibility Studies1201753150.020 Why?
Antineoplastic Combined Chemotherapy Protocols12024118780.010 Why?
Lung12021100990.010 Why?
Disease Progression12019136710.010 Why?
Pilot Projects1201487410.010 Why?
Follow-Up Studies12021393480.010 Why?
Predictive Value of Tests12014154540.010 Why?
Risk Assessment12019243150.010 Why?
Combined Modality Therapy1200985420.010 Why?
Infant, Newborn12016264220.010 Why?
Diagnosis, Differential12009130140.010 Why?
Immunotherapy1200947550.010 Why?
Risk Factors12019749440.010 Why?
Child12020809170.010 Why?
Signal Transduction12009236450.000 Why?
Dulery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (105)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.